Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.
Press releases published on September 4, 2025
Oculis and EURETINA Announce the Winner of the Ramin Tadayoni Award 2025
GlobeNewswire
·
September 4, 2025
ZUG, Switzerland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, today …
OPSEU/SEFPO and CUPE Ontario community and social services workers launch “Worth Fighting For” coordinated bargaining campaign at rally in Hamilton
GlobeNewswire
·
September 4, 2025
Hamilton, Ontario, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Today, hundreds of OPSEU/SEFPO and CUPE Ontario workers and labour allies rallied in Hamilton to demand immediate, long-term funding for community and social services; affirming their commitment to …
Global Colorectal Surgical Devices Market to Advance at Moderate CAGR of ~8% by 2032 | DelveInsight
GlobeNewswire
·
September 4, 2025
New York, USA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Global Colorectal Surgical Devices Market to Advance at Moderate CAGR of ~8% by 2032 | DelveInsight The colorectal surgical devices market is predicted to surge owing to the rising incidence of colorectal …
Reverse Stock Split Strengthens HealthLynked’s Market Position as Company Scales AI-Driven Healthcare Platform
GlobeNewswire
·
September 4, 2025
NAPLES, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK) -- Dear Shareholders, I'm writing to share an important update in the continued evolution of HealthLynked Corp. that reflects our commitment to long-term growth …
OSE Immunotherapeutics: A Clear Strategy, Balanced Governance, and a Firm Course toward Value Creation
GlobeNewswire
·
September 4, 2025
OSE Immunotherapeutics: A Clear Strategy, Balanced Governance, and a Firm Course toward Value Creation NANTES, France – September 4, 2025, 6 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) reaffirms its strategic commitment to value …
OSE Immunotherapeutics : une stratégie claire, une gouvernance équilibrée, un cap affirmé vers la création de valeur
GlobeNewswire
·
September 4, 2025
OSE Immunotherapeutics : une stratégie claire, une gouvernance équilibrée, un cap affirmé vers la création de valeur NANTES, France – 4 septembre 2025, 6 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) réaffirme, à l’approche de l’ …
Dr. Gregory Facemyer Scholarship Launches Nationwide Essay Contest for Aspiring Medical Doctors
GlobeNewswire
·
September 4, 2025
YOUNGSTOWN, Ohio, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The Dr. Gregory Facemyer Scholarship for Medical Students officially opens its application cycle, inviting undergraduate students across the United States to submit original essays that explore the …
Legend Senior Living Welcomes Annalisa Hahn as Senior Vice President of Sales and Marketing
GlobeNewswire
·
September 4, 2025
WICHITA, Kan., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living, a nationally recognized senior living provider with more than 70 residences across seven states, is pleased to announce the appointment of Annalisa Hahn as Senior Vice President of …
Bay Area Lyme Foundation Launches Bay Area Lyme Ventures as First Impact Investment Fund to Support Entrepreneurs and Companies Advancing Lyme Disease Solutions
GlobeNewswire
·
September 4, 2025
PORTOLA VALLEY, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced the launch of Bay Area Lyme Ventures (Lyme Ventures), a bold new impact fund that is the first …
AIM ImmunoTech Highlights Growing Body of Compelling Data of Ampligen for the Treatment of Pancreatic Cancer at Conference in Poland
GlobeNewswire
·
September 4, 2025
Latest progress from lead program Ampligen for the treatment of pancreatic cancer highlighted at the International 5th Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care (MSCI MSCS-2025); Presentation now available here Ampligen has …
PridCor Therapeutics Reports Positive Long COVID Case Series with Combination Antiviral Regimen
GlobeNewswire
·
September 4, 2025
-New Preprint: PridCor Therapeutics LLC has released a pre-print detailing a case series of 15 patients with Long COVID (LC) who were given a continuous regimen of 120-days of valacyclovir and celecoxib with a pulsed 15-day treatment of Paxlovid ( …
Really Global Launches Global Mental Health Marketplace with 2000+ Search Filters Connecting Clients to Providers in 200+ Countries
GlobeNewswire
·
September 4, 2025
San Francisco, CA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Really Global today announced the launch of its comprehensive mental health marketplace that connects clients with therapists, psychologists, nurse practitioners, social workers, coaches, and mentors …
The University of Alabama and GATC Health Unveil Strategic Program to Accelerate Therapeutic Discovery and Development
GlobeNewswire
·
September 4, 2025
IRVINE, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development, today announced the launch of a strategic program with The University of …
Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina
GlobeNewswire
·
September 4, 2025
LAS VEGAS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Cardiac Biotech Solutions, Inc. (OTCID: CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products, today announced the execution of a new …
Silexion Therapeutics Announces Selection of Contract Research Organization to Support Upcoming Phase 2/3 Clinical Trials for SIL204
GlobeNewswire
·
September 4, 2025
Strategic CRO to Support Path to Phase 2/3 Trials Following Recently Demonstrated Groundbreaking 97% Inhibition Rates for SIL204 Phase 2/3 Clinical Trials Expected to Commence in First Half of 2026 Following Q4 2025 and Q1 2026 Regulatory Submissions CRO …
Vireo Growth Inc. Comments on Recent Market Activity; Company Unaware of Any Material Change
GlobeNewswire
·
September 4, 2025
MINNEAPOLIS , Sept. 04, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), at the request of the Canadian Investment Regulatory Organization (“CIRO”), today confirmed that Company management is unaware of any …
Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York
GlobeNewswire
·
September 4, 2025
REYKJAVIK, Iceland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Morgan Stanley …
Hydreight Announces Closing of its Oversubscribed $11.5 Million Convertible Debenture Offering, Including Full Exercise of Over-Allotment Option
GlobeNewswire
·
September 4, 2025
VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) (“Hydreight” or the “Company”), a leader in nationwide digital healthcare solutions, is pleased to announce that it has closed …
Philips launches smart telemetry platform for cardiac monitoring that provides continuous, enterprise-wide connectivity beyond the bedside
GlobeNewswire
·
September 4, 2025
September 4, 2025 Empowering clinical teams to respond to surges, track usage and ease workflows with user-friendly touchscreen technology for telemetry patients on the move Cambridge, Massachusetts – Philips, a global leader in health technology, today …
LogicMark Becomes First to Integrate Medication Reminders into Medical Alert Technology
GlobeNewswire
·
September 4, 2025
LOUISVILLE, Ky., Sept. 04, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK) (the “Company”), a provider of personal emergency response systems (PERS), health communication devices, and technology for the growing care economy, today announced the launch …